Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AREV Life Sciences Global Corp C.AREV

Alternate Symbol(s):  AREVF

AREV Life Sciences Global Corp. is a Canada-based biotechnology company engaged in the discovery and commercialization of solutions for health and wellness. It produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well... see more

Recent & Breaking News (CSE:AREV)

AREV Life Sciences Global Corp. Applauds Passage of Bill C-368

TheNewsWire May 31, 2024

AREV Announces Significant Corporate Progress Amid Trading Suspension

TheNewsWire February 6, 2024

CSE Bulletin: Suspensions (AREV, EMER)

Newsfile July 20, 2023

Canadian Investment Regulatory Organization Trading Halt - AREV

Canada NewsWire July 20, 2023

Notice Of Default - Update

TheNewsWire July 10, 2023

Notice of Default - Update

TheNewsWire June 12, 2023

Notice of Default - Update

TheNewsWire May 29, 2023

Notice of Default - Update

TheNewsWire May 15, 2023

AREV Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of Traditional Medicine

TheNewsWire May 9, 2023

AREV Life Sciences Global Corp. Announces Filing of Application for Management Cease Trade Order

TheNewsWire May 4, 2023

AREV Life Sciences Global Corp. Announces Filing of Application for Management Cease Trade Order

TheNewsWire April 27, 2023

AREV Terminates Private Placement and Term Sheet with Fiberlab, Inc.

TheNewsWire March 27, 2023

AREV Signs Term Sheet with Fiberlab, Inc.

TheNewsWire March 15, 2023

AREV Life Sciences Provides Annual Review for 2022 and Operational Update

TheNewsWire February 28, 2023

Team from Queensland Brain Institute Identifies New Hericerin Derivitives from Lions Mane that Boost Nerve Growth and Enhances Memory

TheNewsWire February 15, 2023

Arev Issues Incentive Stock Options

TheNewsWire January 16, 2023

Arev Board Change

TheNewsWire January 9, 2023

AREV Annual General Meeting Results

TheNewsWire January 4, 2023

AREV Issues Shares for Debt

TheNewsWire November 9, 2022

AREV's Issues Shares for Debt

TheNewsWire November 8, 2022